Garlico Herbal Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-11-2024
- Paid Up Capital ₹ 0.10 M
as on 17-11-2024
- Company Age 14 Year,
- Last Filing with ROC 31 Mar 2023
- Revenue -43.61%
(FY 2023)
- Profit -93.35%
(FY 2023)
- Ebitda -42.36%
(FY 2023)
- Net Worth -0.47%
(FY 2023)
- Total Assets -5.96%
(FY 2023)
About Garlico Herbal
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Milind Jilhewar and Praneeta Jilhewar serve as directors at the Company.
- CIN/LLPIN
U01100MP2010PTC025052
- Company No.
025052
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Dec 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Mandsaur, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Garlico Herbal Private Limited offer?
Garlico Herbal Private Limited offers a wide range of products and services, including Herbs, Turmeric, Women Care, Women Care Supplements, Shilajit (Men Sexual Wellness), Health Conditions, Mental Wellness, Popular Category, Bone & Joint Care, Bone, Joint & Muscle Care.
Who are the key members and board of directors at Garlico Herbal?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Milind Jilhewar  | Managing Director | 28-Dec-2010 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Praneeta Jilhewar | Director | 28-Dec-2010 | Current |
Financial Performance of Garlico Herbal.
Garlico Herbal Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 43.61% decrease. The company also saw a substantial fall in profitability, with a 93.35% decrease in profit. The company's net worth dipped by a decrease of 0.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Garlico Herbal?
In 2023, Garlico Herbal had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Immuno Natural Oils Private LimitedActive 42 years 4 monthsMilind Jilhewar and Praneeta Jilhewar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Garlico Herbal?
Unlock and access historical data on people associated with Garlico Herbal, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Garlico Herbal, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Garlico Herbal's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
